Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study
Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 5, pp. 506-514
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Cognitive Effects of Cancer and Cancer Treatments
Tim A. Ahles, James C. Root
Annual Review of Clinical Psychology (2018) Vol. 14, Iss. 1, pp. 425-451
Open Access | Times Cited: 274
Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment
Loredana Dinapoli, Giuseppe Colloca, Beatrice Di Capua, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 3
Open Access | Times Cited: 113
Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies
Aicha B. C. Dijkshoorn, Haike E. van Stralen, Maurits Sloots, et al.
Psycho-Oncology (2021) Vol. 30, Iss. 5, pp. 635-648
Open Access | Times Cited: 108
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study
Jeanne S. Mandelblatt, Brent J. Small, George Luta, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3211-3222
Open Access | Times Cited: 153
Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment
Victoria Bray, Haryana M. Dhillon, Janette Vardy
Journal of Cancer Survivorship (2018) Vol. 12, Iss. 4, pp. 537-559
Closed Access | Times Cited: 149
Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study
Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3231-3239
Open Access | Times Cited: 132
Cognitive Changes in Cancer Survivors
Sara Hardy, Kevin R. Krull, Jeffrey S. Wefel, et al.
American Society of Clinical Oncology Educational Book (2018), Iss. 38, pp. 795-806
Closed Access | Times Cited: 127
COVID-19 Lockdown and Its Adverse Impact on Psychological Health in Breast Cancer
Jessica Swainston, Bethany Chapman, Elizabeth A. Grunfeld, et al.
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 122
Cognitive complaints in cancer survivors and expectations for support: Results from a web–based survey
Marie Lange, Idlir Licaj, Bénédicte Clarisse, et al.
Cancer Medicine (2019) Vol. 8, Iss. 5, pp. 2654-2663
Open Access | Times Cited: 112
A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment
Todd S. Horowitz, Jerry Suls, Melissa Treviño
Trends in Neurosciences (2018) Vol. 41, Iss. 8, pp. 493-496
Closed Access | Times Cited: 109
Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors
Florence Joly, Marie Lange, Mélanie Dos Santos, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1896-1896
Open Access | Times Cited: 108
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Samantha Mayo, Maryam B. Lustberg, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 6, pp. 2821-2840
Closed Access | Times Cited: 108
Meta-Analysis of the Efficacy of Virtual Reality–Based Interventions in Cancer-Related Symptom Management
Yingchun Zeng, Jun Zhang, Andy S. K. Cheng, et al.
Integrative Cancer Therapies (2019) Vol. 18
Open Access | Times Cited: 103
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren, Diana Boriero, Luksana Chaiswing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 99
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx
Lynne I. Wagner, Robert J. Gray, Joseph A. Sparano, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 17, pp. 1875-1886
Open Access | Times Cited: 82
Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial
Juan Zhang, Jie Chen, Boni Ding, et al.
European Journal of Cancer (2021) Vol. 161, pp. 10-22
Closed Access | Times Cited: 78
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
Ashley M. Henneghan, Kathleen Van Dyk, Tara Kaufmann, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 12, pp. 1625-1633
Open Access | Times Cited: 76
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis
AnnaLynn M. Williams, Carly Paterson Khan, Charles E. Heckler, et al.
Breast Cancer Research and Treatment (2021) Vol. 187, Iss. 1, pp. 275-285
Open Access | Times Cited: 59
Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice
TaeHyun Kim, Benjamin T. James, Martin C. Kahn, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 737
Open Access | Times Cited: 12
Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy
AnnaLynn M. Williams, Raven Shah, Michelle Shayne, et al.
Journal of Neuroimmunology (2017) Vol. 314, pp. 17-23
Open Access | Times Cited: 84
Breast cancer treatment and its effects on aging
Leslie Chang, Lauren S Weiner, Sheri J. Hartman, et al.
Journal of Geriatric Oncology (2018) Vol. 10, Iss. 2, pp. 346-355
Open Access | Times Cited: 75
Page 1 - Next Page

Scroll to top